MX2019011678A - Alcaloides de berberina en la prevencion y/o tratamiento de una enfermedad intestinal. - Google Patents

Alcaloides de berberina en la prevencion y/o tratamiento de una enfermedad intestinal.

Info

Publication number
MX2019011678A
MX2019011678A MX2019011678A MX2019011678A MX2019011678A MX 2019011678 A MX2019011678 A MX 2019011678A MX 2019011678 A MX2019011678 A MX 2019011678A MX 2019011678 A MX2019011678 A MX 2019011678A MX 2019011678 A MX2019011678 A MX 2019011678A
Authority
MX
Mexico
Prior art keywords
prevention
treatment
intestinal disease
berberine
berberine alkaloids
Prior art date
Application number
MX2019011678A
Other languages
English (en)
Inventor
Xiang Yu David
Xiao Zhicheng
Pouton Colin
He Zhiyong
Original Assignee
IRP Health Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2017901105A external-priority patent/AU2017901105A0/en
Application filed by IRP Health Pty Ltd filed Critical IRP Health Pty Ltd
Publication of MX2019011678A publication Critical patent/MX2019011678A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/116—Heterocyclic compounds
    • A23K20/132—Heterocyclic compounds containing only one nitrogen as hetero atom
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/116—Heterocyclic compounds
    • A23K20/121—Heterocyclic compounds containing oxygen or sulfur as hetero atom
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/195—Antibiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K30/00—Processes specially adapted for preservation of materials in order to produce animal feeding-stuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K40/00—Shaping or working-up of animal feeding-stuffs
    • A23K40/10—Shaping or working-up of animal feeding-stuffs by agglomeration; by granulation, e.g. making powders
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/30—Feeding-stuffs specially adapted for particular animals for swines
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/70—Feeding-stuffs specially adapted for particular animals for birds
    • A23K50/75—Feeding-stuffs specially adapted for particular animals for birds for poultry
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/473—Quinolines; Isoquinolines ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Animal Husbandry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Birds (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Esta invención se relaciona con alcaloides de berberina, las formulaciones de los mismos y su uso para la prevención y/o tratamiento de una enfermedad infecciosa, en especial una enfermedad provocada por C. perfringens y Eimeria en animales. La invención también se relaciona con mejorar el índice de conversión alimenticia en un animal destinado a la producción de alimentos mediante la administración de composiciones de berberina.
MX2019011678A 2017-03-28 2018-01-02 Alcaloides de berberina en la prevencion y/o tratamiento de una enfermedad intestinal. MX2019011678A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU2017901105A AU2017901105A0 (en) 2017-03-28 Berberine alkaloids in the prevention and/or treatment of intestinal disease
AU2017903261A AU2017903261A0 (en) 2017-08-15 Berberine alkaloids in the prevention and/or treatment of intestinal disease
PCT/AU2018/050002 WO2018176079A1 (en) 2017-03-28 2018-01-02 Berberine alkaloids in the prevention and/or treatment of intestinal disease

Publications (1)

Publication Number Publication Date
MX2019011678A true MX2019011678A (es) 2020-02-12

Family

ID=63673822

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2019011678A MX2019011678A (es) 2017-03-28 2018-01-02 Alcaloides de berberina en la prevencion y/o tratamiento de una enfermedad intestinal.
MX2019011714A MX2019011714A (es) 2017-03-28 2018-03-28 Formulaciones de alcaloides de berberina en la prevencion y/o tratamiento de enfermedades infecciosas.

Family Applications After (1)

Application Number Title Priority Date Filing Date
MX2019011714A MX2019011714A (es) 2017-03-28 2018-03-28 Formulaciones de alcaloides de berberina en la prevencion y/o tratamiento de enfermedades infecciosas.

Country Status (10)

Country Link
US (3) US20230404107A1 (es)
EP (2) EP3600304A4 (es)
KR (2) KR20190139236A (es)
CN (2) CN110650739A (es)
AU (4) AU2018241231B2 (es)
BR (2) BR112019020225A2 (es)
CA (2) CA3057858A1 (es)
MX (2) MX2019011678A (es)
PH (2) PH12019502240A1 (es)
WO (2) WO2018176079A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3810137A4 (en) 2018-05-29 2022-03-09 IRP Health Pty Ltd NITROIMIDAZOLE FORMULATIONS
WO2021072473A1 (en) * 2019-10-14 2021-04-22 IRP Health Pty Ltd Antimicrobials as feed preservatives
WO2022192535A1 (en) * 2021-03-10 2022-09-15 Cornell University Methods for improving poultry health
CN113817842B (zh) * 2021-09-26 2024-05-03 中国农业大学 与鸡柔嫩艾美耳球虫地克珠利耐药性相关的snp分子标记及其应用

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002021933A2 (de) * 2000-09-15 2002-03-21 Hermann Roth Futtermittel oder futtermittelzusatz als leistungsförderer oder appetitförderer für nutztiere
WO2004093876A2 (en) * 2003-04-03 2004-11-04 The Board Of Trustees Of The University Of Illinois Composition containing berberine or a derivative thereof and an antimicrobial agent or an antibiotic agent, and their use for treating oral pathogens and other disorders
US8927565B2 (en) * 2003-08-28 2015-01-06 Australian Biomedical Company Pty. Ltd. Compositions for veterinary and medical applications
US8003136B2 (en) * 2004-03-03 2011-08-23 Randy Beavers Standardization of botanical products utilizing biological activity as a marker
US20070098649A1 (en) * 2004-03-22 2007-05-03 The Board Of Trustees Of The University Of Illinois Method and composition for controlling oral pathogens
WO2006120495A1 (fr) * 2005-05-13 2006-11-16 Advanced Scientific Developements Composition pharmaceutique comprenant un antiviral, an antitumoral ou un antiparasitaire, et un actif choisi parmi le carveol, le thymol, l’eugenol, le borneol et le carvacrol
CN101467999A (zh) * 2007-12-25 2009-07-01 郑州后羿制药有限公司 一种盐酸小檗碱复方制剂
CN101411717B (zh) * 2008-11-07 2010-10-13 北京宏泰康达医药科技有限公司 一种治疗急性肠炎和痢疾的组合物
US20130072513A1 (en) * 2009-04-22 2013-03-21 James Spencer COMBINATIONS OF BERBERINE, ARTEMISININ, Loperamide AND THEIR DERIVATIVES TO TREAT MALARIA, DIARRHEA, TRAVELERS' DIARRHEA, DYSENTERY, DENGUE FEVER, PARASITES, CHOLERA AND VIRUSES
CN102475193A (zh) * 2010-12-29 2012-05-30 吉林省农业科学院 一种抗热应激植物提取物饲料添加剂及其制备方法
US9023345B2 (en) * 2011-03-01 2015-05-05 Novus International, Inc. Methods for improving gut health
CN102151260B (zh) * 2011-03-12 2012-12-05 暨南大学 穿心莲内酯和黄连素组合物及其应用
CN102526657B (zh) * 2011-12-16 2013-12-04 青岛绿曼生物工程有限公司 一种治疗猪增生性肠炎的复方蜂胶组合物及其制备方法
CN106620189B (zh) * 2012-06-06 2021-11-19 上海交通大学 改善肠道菌群结构的方法及应用
CN103768252A (zh) * 2012-10-25 2014-05-07 蔡田湉 用于防治初生牛肾病的保健品
CN104208238B (zh) * 2013-09-29 2016-08-10 郑州后羿制药有限公司 一种用于治疗鸡球虫病的中药组合物及其制备方法
CN103584256B (zh) * 2013-11-26 2015-07-22 青岛嘉瑞生物技术有限公司 一种利用石莼资源化开发的天然食品保鲜剂及制备方法
CN103947869A (zh) * 2014-04-08 2014-07-30 安徽壮大饲料有限公司 用于预防蛋鸡产蛋期患大肠杆菌病的预混料
KR101656929B1 (ko) * 2014-06-02 2016-09-13 씨제이제일제당 (주) 반추동물의 메탄 생성 저감용 사료 첨가제 조성물
CN104286422A (zh) * 2014-11-18 2015-01-21 广东康达尔农牧科技有限公司 一种高抗病性的复合家禽饲料添加剂
CN105831392B (zh) * 2015-01-16 2020-12-22 北京大北农科技集团股份有限公司 一种猪用饲料添加剂及其饲料
CN104605164A (zh) * 2015-02-13 2015-05-13 安徽恒源药业有限公司 一种畜用饲料脱霉添加剂
CN106389717A (zh) * 2015-07-21 2017-02-15 沈阳伟嘉牧业技术有限公司 一种用于治疗仔猪耐药性大肠杆菌病的中药组合物
CN105056121A (zh) * 2015-08-07 2015-11-18 北京农业职业学院 一种含有茜草的抗柔嫩艾美耳球虫病的中药组方
CN106309464A (zh) * 2015-10-10 2017-01-11 长沙博海生物科技有限公司 一种用于禽畜增免抗病毒的中药成分的组合物、制备方法及应用
CN105410441A (zh) * 2015-12-04 2016-03-23 山东新希望六和集团有限公司 一种含益生菌肉鸡配合饲料及其制备方法
CN106490337A (zh) * 2017-01-16 2017-03-15 胡润四 一种发酵猪饲料
CN107669543A (zh) * 2017-10-11 2018-02-09 广州市禾基生物科技有限公司 一种防腐剂及其制备方法

Also Published As

Publication number Publication date
AU2024219381A1 (en) 2024-09-26
EP3600304A4 (en) 2021-01-06
WO2018176093A1 (en) 2018-10-04
CN110709080A (zh) 2020-01-17
CN110650739A (zh) 2020-01-03
KR20190139908A (ko) 2019-12-18
US20210329946A1 (en) 2021-10-28
BR112019020228A2 (pt) 2020-06-16
US20230404107A1 (en) 2023-12-21
EP3600304A1 (en) 2020-02-05
AU2018241245B2 (en) 2024-05-23
BR112019020225A2 (pt) 2020-04-22
WO2018176079A8 (en) 2020-02-13
AU2018241231B2 (en) 2024-06-06
PH12019502240A1 (en) 2020-07-06
WO2018176079A1 (en) 2018-10-04
KR20190139236A (ko) 2019-12-17
AU2024213117A1 (en) 2024-09-12
EP3600305A1 (en) 2020-02-05
EP3600305A4 (en) 2021-06-16
PH12019502241A1 (en) 2020-07-06
WO2018176093A8 (en) 2018-11-15
MX2019011714A (es) 2020-02-12
CA3057858A1 (en) 2018-10-04
CA3057996A1 (en) 2018-10-04
AU2018241245A1 (en) 2019-11-07
US20240306670A1 (en) 2024-09-19
AU2018241231A1 (en) 2019-11-07

Similar Documents

Publication Publication Date Title
PH12019502241A1 (en) Berberine alkaloids in the prevention and/or treatments of intestinal disease
MX2019009571A (es) 2-heteroaril-3-oxo-2,3-dihidropiridazin-4-carboxamidas.
PH12020550341A1 (en) Niraparib formulations
PH12019502363A1 (en) Phenyl-2-hydroxy-acetylamino-2-methyl-phenyl compounds
PH12017500401A1 (en) Therapeutic compounds as inhibitors of the orexin-1 receptor
MX2017006437A (es) Compuestos espiroisoquinolin-1,4'-piperidinicos con actividad multimodal contra el dolor.
CR20210532A (es) Protacs que degradan el receptor de estrógeno
PH12018500315A1 (en) Fumagillol heterocyclic compounds and methods of making and using same
MX2018000419A (es) Derivados de amida sustituida que tienen actividad multimodal contra el dolor.
NZ744982A (en) Therapeutic compounds
PH12020550616A1 (en) Compounds and pharmaceutical compositions thereof for use in the treatment of fibrotic diseases
PH12019502150A1 (en) Compounds and methods for the treatment of parasitic diseases
PH12015500823A1 (en) Modified release formulations for oprozomib
ZA202001295B (en) Thiazolopyridine derivatives as adenosine receptor antagonists
MX2017006513A (es) Compuestos de tipo 1,9-diazaespiroundecano con actividad multimodal contra el dolor.
MX2018014129A (es) Composiciones farmaceuticas de oligomero de morfolino fosforodiamidato.
PH12018502280A1 (en) Tetrahydropyran and thiopyran derivatives having multimodal activity against pain
PH12016501205B1 (en) Catecholamine production accelerator, and therapeutic and preventive agent and therapeutic and preventive food composition for diseases caused by catecholamine deficiency
WO2015044961A3 (en) Pharmaceutical composition comprising capecitabine and cyclophosphamide
ES2478690A1 (es) Extractos fenólicos de uncaria tomentosa l. (uña de gato) que contienen procianidinas, propelargonidinas y flavanolignanos, procedimiento de obtención y sus aplicaciones
GB2550750A (en) Anthelmintic compounds
MX2018003564A (es) 1,4-benzodiazepinas biheteroarilo sustituidas y usos de las mismas para el tratamiento del cancer.
PH12020500120A1 (en) Pharmaceutical compositions
MX2017005103A (es) Proceso de sintesis de hidroxi-triacilgliceroles y usos de los mismos para la prevencion y el tratamiento de enfermedades.
TN2015000524A1 (en) Pharmaceutical compositions